Literature DB >> 24062892

A strategy for addressing aspirin hypersensitivity in patients requiring urgent PCI.

Patrick Schiano1, Philippe Gabriel Steg, Franck Barbou, Jacques Monségu.   

Abstract

Aspirin is key to the treatment of acute myocardial infarction, particularly if stent implantation is considered. In patients with a history of hypersensitivity to aspirin, the optimal management of ST-segment elevation acute myocardial infarction is unclear. We suggest a strategy for addressing this problem by performing percutaneous coronary intervention with antiplatelet therapy by intravenous glycoprotein IIb/IIIa receptor blockers and performing rapid oral desensitization in the ensuing hours, once the patient has stabilized.

Entities:  

Keywords:  Acute myocardial infarction; allergy; aspirin; desensitisation

Year:  2012        PMID： 24062892      PMCID： PMC3760547          DOI： 10.1177/2048872612441580

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN： 2048-8726


  9 in total

Review 1.  A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis.

Authors:  Taral N Patel; Anthony A Bavry; Dharam J Kumbhani; Stephen G Ellis
Journal:  Am J Cardiol       Date:  2006-04-21       Impact factor: 2.778

2.  Transradial rescue angioplasty for failed thrombolysis in acute myocardial infarction: reperfusion with reduced vascular risk.

Authors:  T S N Lo; I R Hall; R Jaumdally; P M Davison; K Dickinson; D J Hildick-Smith; J Nolan
Journal:  Heart       Date:  2006-08       Impact factor: 5.994

Review 3.  Aspirin sensitivity: implications for patients with coronary artery disease.

Authors:  Raghava R Gollapudi; Paul S Teirstein; Donald D Stevenson; Ronald A Simon
Journal:  JAMA       Date:  2004-12-22       Impact factor: 56.272

4.  Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema.

Authors:  J T Wong; C S Nagy; S J Krinzman; J A Maclean; K J Bloch
Journal:  J Allergy Clin Immunol       Date:  2000-05       Impact factor: 10.793

5.  Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction.

Authors:  P Jong; E A Cohen; W Batchelor; C Lazzam; C Kreatsoulas; M K Natarajan; B H Strauss
Journal:  Am Heart J       Date:  2001-02       Impact factor: 4.749

6.  Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting.

Authors:  Stéphane Silberman; Catherine Neukirch-Stoop; Philippe Gabriel Steg
Journal:  Am J Cardiol       Date:  2005-02-15       Impact factor: 2.778

7.  Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

Authors:  Frans Van de Werf; Diego Ardissino; Amadeo Betriu; Dennis V Cokkinos; Erling Falk; Keith A A Fox; Desmond Julian; Maria Lengyel; Franz-Josef Neumann; Witold Ruzyllo; Christian Thygesen; S Richard Underwood; Alec Vahanian; Freek W A Verheugt; William Wijns
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

Review 8.  Pathogenesis, diagnosis, and treatment of aspirin intolerance.

Authors:  Claudia Jenneck; Uwe Juergens; Markus Buecheler; Natalija Novak
Journal:  Ann Allergy Asthma Immunol       Date:  2007-07       Impact factor: 6.347

9.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321
  9 in total
  3 in total

1.  Psoriasis is an independent predictor of increased risk of allergic reaction during percutaneous coronary interventions. Big data analysis from the Polish National PCI Registry (ORPKI).

Authors:  Zbigniew Siudak; Kalina Wysocka-Dubielecka; Krzysztof Malinowski; Artur Dziewierz; Tomasz Tokarek; Krzysztof Plens; Dariusz Dudek
Journal:  Cardiol J       Date:  2018-08-29       Impact factor: 2.737

Review 2.  Management standards for stable coronary artery disease in India.

Authors:  Sundeep Mishra; Saumitra Ray; Jamshed J Dalal; J P S Sawhney; S Ramakrishnan; Tiny Nair; S S Iyengar; V K Bahl
Journal:  Indian Heart J       Date:  2016-12-09

Review 3.  Management Protocols of stable coronary artery disease in India: Executive summary.

Authors:  Sundeep Mishra; Saumitra Ray; Jamshed J Dalal; J P S Sawhney; S Ramakrishnan; Tiny Nair; S S Iyengar; Vinay K Bahl
Journal:  Indian Heart J       Date:  2016 Nov - Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.